Adrenoleukodystrophy

Adrenoleukodystrophy (ALD)

About Adrenoleukodystrophy

Adrenoleukodystrophy (ALD) is a rare inherited genetic disorder that primarily affects the brain, spinal cord, and adrenal glands. It damages the myelin, the protective covering that surrounds nerve cells and allows them to transmit signals properly. As myelin breaks down, nerve function can progressively deteriorate. ALD is caused by changes (mutations) in the ABCD1 gene. The condition primarily affects males, although females who carry the altered gene may also develop symptoms, usually in a milder form. There are several forms of ALD. The most severe form in children, childhood cerebral ALD, can cause progressive problems with learning, behavior, movement, vision, hearing, and other neurological functions. Other forms may primarily affect the adrenal glands or the spinal cord and peripheral nerves.

Symptoms of Adrenoleukodystrophy

Symptoms vary depending on the type of ALD and the age at which it develops. They may include:
  • Muscle weakness
  • Muscle spasms or stiffness
  • Seizures
  • Difficulty swallowing
  • Slurred speech
  • Hearing impairment or hearing loss
  • Impaired vision, which may progress to blindness
  • Difficulty walking or problems with coordination
  • Changes in behavior or personality
  • Hyperactivity or difficulty concentrating
  • Problems with memory, learning, or school performance
  • Loss of appetite
  • Unexplained weight loss
  • Nausea and vomiting
  • Progressive paralysis
  • Loss of bladder or bowel control
  • Severe neurological impairment
  • Coma in advanced cases
Some people with ALD develop adrenal insufficiency (Addison’s disease). This can cause fatigue, weakness, weight loss, low blood pressure, abdominal symptoms, low blood sugar, and darkening of the skin.

Causes of Adrenoleukodystrophy

ALD is caused by a mutation in the ABCD1 gene, which is located on the X chromosome. This gene provides instructions for making a protein involved in transporting certain fatty acids into peroxisomes, structures within cells that help break down fatty acids. When the ABCD1 gene does not function properly, very-long-chain fatty acids (VLCFAs) can accumulate, particularly in the nervous system and adrenal glands. Their buildup is associated with damage to myelin and adrenal tissue. Because ALD is X-linked, males are generally more severely affected because they have one X chromosome. Females have two X chromosomes and may have a milder form of the disease, although some women can develop significant neurological symptoms.

Types of Adrenoleukodystrophy

ALD can occur in different forms:

Childhood cerebral ALD

This form usually begins during childhood and can progress rapidly. Early symptoms may include difficulty learning, behavioral changes, declining school performance, vision or hearing problems, and problems with coordination. Without appropriate treatment, severe neurological disability can develop.

Adrenomyeloneuropathy (AMN)

AMN is a form that generally begins in adulthood. It mainly affects the spinal cord and peripheral nerves and may cause progressive stiffness and weakness of the legs, difficulty walking, balance problems, and bladder or bowel difficulties.

Adrenal insufficiency

Some people with ALD primarily develop adrenal gland dysfunction. The adrenal glands produce hormones that are important for maintaining blood pressure, blood sugar, metabolism, and the body’s response to stress. Adrenal insufficiency can occur before neurological symptoms and requires prompt medical management.

Risk Factors

The major risk factor for ALD is having an ABCD1 gene mutation. A family history of ALD can increase the likelihood of inheriting the condition. Genetic counseling and testing may be recommended for affected families because the disorder can be passed from one generation to another.

Diagnosis

Early diagnosis is important because some treatments may be most effective before significant neurological damage occurs. A doctor may recommend:
  • Blood testing to measure very-long-chain fatty acid levels
  • Genetic testing to identify an ABCD1 gene mutation
  • Magnetic resonance imaging (MRI) of the brain to look for characteristic changes
  • Adrenal hormone testing to assess adrenal gland function
  • Neurological and developmental assessments
  • Hearing and vision evaluations when appropriate
  • Genetic counseling and testing for family members when indicated
Newborn screening for ALD is available in some countries and can help identify affected children before symptoms appear.

Treatment of Adrenoleukodystrophy

There is currently no universal cure for ALD, but treatment can help manage the condition and, in selected patients, slow or prevent progression.

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) may be considered for certain boys with early-stage childhood cerebral ALD, particularly when brain MRI shows evidence of disease but neurological impairment is still limited. Treatment is generally most beneficial when performed before substantial neurological deterioration. HSCT carries significant risks and is not appropriate for every person with ALD. The decision requires assessment by a specialized medical team.

Adrenal hormone replacement

People who develop adrenal insufficiency may require lifelong hormone replacement therapy, usually with glucocorticoids and, in some cases, mineralocorticoids. Regular monitoring is important because an untreated adrenal crisis can be life-threatening.

Supportive treatment

Supportive care depends on the symptoms and may include:
  • Physiotherapy to maintain mobility and muscle function
  • Occupational therapy
  • Speech and swallowing therapy
  • Nutritional support
  • Treatment for seizures
  • Management of muscle stiffness and spasms
  • Hearing and vision support
  • Assistive devices for mobility
  • Psychological, educational, and behavioral support
  • Palliative care for advanced disease when appropriate

When to See a Doctor

A child with unexplained changes in learning, behavior, vision, hearing, coordination, or movement should be evaluated by a healthcare professional, particularly when there is a family history of ALD. Urgent medical attention is required for symptoms that may indicate adrenal crisis, such as severe weakness, vomiting, abdominal pain, confusion, fainting, very low blood pressure, or loss of consciousness.

Specialists to Visit

Depending on the symptoms and treatment needs, care may involve:
  • Neurologist
  • Endocrinologist
  • Hematologist/Stem Cell Transplant Specialist
  • Gastroenterologist
  • Hepatologist, when liver-related evaluation is required
  • Physiotherapist
  • Speech and Swallowing Therapist
  • Genetic Counselor
A specialized multidisciplinary team is often important because ALD can affect several body systems.

Living With Adrenoleukodystrophy

ALD is a lifelong condition that requires ongoing medical monitoring. Regular neurological assessments, adrenal function testing, and appropriate imaging can help doctors identify disease progression and complications. Families may benefit from genetic counseling to understand inheritance patterns, testing options, and the potential risk to other family members. Early identification of affected children can be particularly important because some treatments are time-sensitive.

Frequently Asked Questions

Is adrenoleukodystrophy hereditary?

Yes. ALD is an inherited genetic disorder caused by changes in the ABCD1 gene and is passed through families in an X-linked pattern.

Is adrenoleukodystrophy more common in boys?

Yes. Boys are generally more severely affected because they have only one X chromosome. Women who carry an ABCD1 mutation can also develop symptoms, particularly later in life, although these are often less severe.

Can adrenoleukodystrophy be cured?

There is currently no treatment that cures all forms of ALD. However, selected children with early cerebral ALD may benefit from hematopoietic stem cell transplantation, while adrenal insufficiency can be treated with hormone replacement.

Can ALD be detected before symptoms appear?

Yes. Genetic testing and measurement of very-long-chain fatty acids can help identify ALD. In some regions, newborn screening is also available.

Can adrenal insufficiency be treated?

Yes. Adrenal insufficiency caused by ALD can usually be managed with appropriate hormone replacement therapy. Patients require ongoing monitoring and may need increased steroid doses during illness, injury, or other physical stress.

Does every person with ALD develop severe neurological problems?

No. ALD has a variable course. Some people develop childhood cerebral disease, while others primarily develop adrenal insufficiency or adult-onset neurological symptoms.

References

https://www.mayoclinic.org
https://en.wikipedia.org
https://www.healthline.com
https://www.webmd.com
http://www.stopald.org

 
Medical Disclaimer: This article is intended for general educational purposes and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Anyone with symptoms suggestive of ALD or a family history of the condition should consult a qualified healthcare professional.

My Mediland
© Copyright 2026 MYMEDILAND. All rights reserved.